What is DKSH acquiring, and why is this acquisition strategically significant according to the news?

DKSH is acquiring P.R. Chemicals Co. Ltd., a Thailand-based distributor specializing in active pharmaceutical ingredients (APIs). According to the news, the acquisition is strategically significant because it marks 'an important step in its performance materials division’s strategy to expand its API platform and strengthen its position in healthcare-related specialty ingredients.'

What are the key operational and financial details disclosed about P.R. Chemicals in the announcement?

The news states that P.R. Chemicals serves over 100 customers, employs 27 people, and reported net sales exceeding CHF11 million in 2025; it distributes APIs across therapeutic areas including pain management, anti-infectives, nutritional health, cardiovascular care, and inflammation. The financial terms of the acquisition were not disclosed, and the transaction is expected to close in Q4 2026, pending customary closing conditions.

DKSH to acquire Thailand-based API distributor

Aug 27, 2026

DKSH Holding agreed to acquire Thailand-based P.R. Chemicals, an API distributor, to expand its healthcare specialty ingredients platform. The undisclosed deal is expected to close in Q4 2026.

chemweek

2026-08-27

DKSH to acquire Thailand-based API distributor

DKSH to acquire Thailand-based API distributor

FAQ